Published in Vaccine Weekly, May 15th, 1995
In February of 1995 the U.S. Food and Drug Administration approved the first hepatitis A virus (HAV) vaccine for use in the United States. The vaccine, manufactured by SmithKline Beecham Biologicals of Philadelphia, and other HAV vaccines are already in use in 40 other countries.
"Recent field trials have show HAV vaccines to be safe and effective, demonstrating an efficacy of greater than 97 percent for the prevention of disease in...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly